InSitu Biologics

Insitu Biologics is a clinical stage pharmaceutical company that is developing a disruptive technology for the treatment of post operative pain management. Post operative pain is one of the leading reasons physicians prescribe opioids and a significant factor in the current opioid crisis in the U.S. InSitu controls pain with one peripheral nerve block injection that provides 5 days of pain management with no opioids. At the end of the treatment period most patients can transition directly to ibuprophen or some other OTC pain medication. This extended relief platform offers new hope to the over 21 million surgical patients whose only other option is opioid treatment. InSite has more than 20 patents on its product and process for the precision delivery of the pain medication. This platform technology also has significant opportunities in cancer, anti-inflammatory and antibiotic drug delivery.


All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.